Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial.

MLA

Solomon, Daniel H., et al. “Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial.” Journal of the American Heart Association, vol. 13, no. 5, Mar. 2024, p. e032095. EBSCOhost, https://doi.org/10.1161/JAHA.123.032095.

APA

Solomon, D. H., Demler, O., Rist, P. M., Santacroce, L., Tawakol, A., Giles, J. T., Liao, K. P., & Bathon, J. M. (2024). Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial. Journal of the American Heart Association, 13(5), e032095. https://doi.org/10.1161/JAHA.123.032095

Chicago

Solomon, Daniel H, Olga Demler, Pamela M Rist, Leah Santacroce, Ahmed Tawakol, Jon T Giles, Katherine P Liao, and Joan M Bathon. 2024. “Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial.” Journal of the American Heart Association 13 (5): e032095. doi:10.1161/JAHA.123.032095.